Annual Conference 2023: Penman says “enough is enough” and repeats call for members to vote for strike action
Dave Penman, General Secretary
“There comes a time for everyone when enough is enough, when the only response can be a demonstrable one that signals to ministers exactly how strongly you feel. That time is now conference,” he added.
Later in the day, while moving an emergency motion on industrial action, Penman told delegates that the intention is that the FDA will start balloting members at the end of May, the ballot will close at the end of June and, if successful, action will take place before summer break. The ballot will include FDA members working for UK government departments, covering both delegated grades and the SCS, and marks the first time the union has run a national strike ballot over pay in 40 years.
Rt Hon. David Gauke, political commentator and former Conservative minister
The former Secretary of State for Work and Pensions, Lord Chancellor and Treasury minister spoke to FDA members about the value of civil servants, the relationship between ministers and officials and why accusations of “the blob” do not reflect reality.
Pippa Crerar, Political Editor at The Guardian
Pippa Crerar spoke to delegates about the principles that drive her investigative journalism, the political climate of the last few years and how the civil service has been caught up in a wider culture war.
Related News
-

Huge industrial transformation
Tom Nathan speaks to TUC General Secretary Paul Nowak about the enormous significance of the Employment Rights Act, his views on working with the civil service and why his next holiday will take place in Milton Keynes.
-

FDA condemns dismissal of Sir Olly Robbins over Mandelson vetting
The FDA has condemned the Prime Minister’s dismissal of Sir Olly Robbins, former FCDO Permanent Secretary, over the vetting of Lord Mandelson for his appointment as Ambassador to the United States.
-

An objective way forward
Katherine Hutchinson speaks to FDA member Rebecca* about her experiences facing difficult circumstances at work, and the ways in which the FDA was able to help her.